Delaware Sample Contracts

[Amended and Restated] Employment Agreement (January 11th, 2019)

[AMENDED AND RESTATED] EMPLOYMENT AGREEMENT (the "Agreement") by and between AmerisourceBergen Corporation, a Delaware corporation (hereinafter the "Company"), and [________] (the "Executive"), executed by the parties hereto on the dates set forth below and dated and effective as of [_________].

Amended and Restated Employment Agreement (January 11th, 2019)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the "Agreement") by and between AmerisourceBergen Corporation, a Delaware corporation (hereinafter the "Company"), and John G. Chou (the "Executive"), executed by the parties hereto on the dates set forth below and dated and effective as of January 11, 2019.

Kaleido Biosciences, Inc. – Kaleido Biosciences, Inc. [Form Of] Officer Indemnification Agreement (January 11th, 2019)
Generex Biotechnology Corporation – Pledge and Security Agreement Confidential Draft: For Discussion Purposes Only (January 11th, 2019)

THIS PLEDGE AND SECURITY AGREEMENT (the "Pledge"), is made and entered into this ___ day of January 2019, ("Effective Date") by and between GENEREX BIOTECHNOLOGY CORPORATION, A Delaware corporation ("Pledgor") and OLAREGEN THERAPEUTIX INC., a Delaware corporation ("Pledgee").

Loan Agreement (January 11th, 2019)

This Loan Agreement (as amended, restated, modified or otherwise supplemented from time to time, this "Agreement") is entered into as of January 8, 2019 (the "Agreement Date"), by and between SemiLEDs Corporation, a corporation organized under the laws of the state of Delaware (the "Borrower"), and J. R. Simplot Company, a corporation organized under the laws of the state of Nevada (the "Lender").

Magna-Lab Inc -Cl A – Promissory Note (January 11th, 2019)

FOR VALUE RECEIVED, the undersigned, Magna-Lab Inc., a New York corporation ("Borrower"), HEREBY PROMISES TO PAY to the order of Magna Acquisition LLC or its registered assigns ( "Lender"), in lawful money of the United States of America, in the manner and at the times provided hereinafter, the principal sum of Three Thousand Four Hundred Dollars (US$3,400), together with Interest (as hereinafter defined) and Default Interest (as hereinafter defined) and all other amounts due and payable pursuant to and in accordance with terms of this Note.

SEACOR Marine Holdings Inc. – Registration Rights Agreement by and Among Seacor Marine Holdings Inc., McCall Properties, Llc and the Members of the Sellers Listed Herein (January 11th, 2019)

This REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made and entered into as of January 9, 2019, by and among SEACOR Marine Holdings Inc., a Delaware corporation (the "Company"), McCall Properties, L.L.C., a Louisiana limited liability company ("McCall Properties") and each of the members of McCall Marine Transportation, L.L.C., a Louisiana limited liability company, N.F. McCall Offshore, L.L.C., a Louisiana limited liability company, and Carlene McCall, L.L.C., a Louisiana limited liability company listed on the signature page hereto (the "Members").

Kaleido Biosciences, Inc. – Kaleido Biosciences, Inc. 2015 Stock Incentive Plan (January 11th, 2019)
THIS AMENDMENT NO. 8 (This Amendment) Dated as of January 11, 2019 Is Entered Into by and Among TAXI MEDALLION LOAN TRUST III, a Delaware Statutory Trust (The Borrower), MEDALLION FUNDING LLC (Successor by Merger to Medallion Funding Corp.), a New York Limited Liability Company (The Transferor), MEDALLION FINANCIAL CORP., a Delaware Corporation (Parent), MEDALLION CAPITAL, INC., a Minnesota Corporation (Medallion Capital), FRESHSTART VENTURE CAPITAL CORP., a New York Corporation (Freshstart And, Together With the Borrower, the Transferor, Parent and Medallion Capital, the MF/Borrower Related P (January 11th, 2019)
Kaleido Biosciences, Inc. – By-Laws of Vl32, Inc. (January 11th, 2019)
Newmarkt Corp. – Common Stock Purchase Warrant Ozop Surgical Corp. (January 11th, 2019)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the issuance of the $150,000.00 senior convertible promissory note to the Holder (as defined below) of even date) (the "Note"), Auctus Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Ozop Surgical Corp., a Nevada corporation (the "Company"), up to 50,000 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated January 7, 2019, by and among the Company

Syros Pharmaceuticals, Inc. – LEASE Between (January 11th, 2019)

This Lease is effective as of January 8, 2019 by and between DIV 35 CPD, LLC, a Massachusetts limited liability company, with its principal place of business at c/o The Davis Companies, 125 High Street, 21st Floor, Boston, Massachusetts 02110 (the Landlord), and Syros Pharmaceuticals, Inc., a Delaware corporation, with an address of 620 Memorial Drive, Suite 300, Cambridge, Massachusetts 02139 (the Tenant).

Cirius Therapeutics, Inc. – Assignment and Assumption of Lease (January 11th, 2019)
Cirius Therapeutics, Inc. – Cirius Therapeutics, Inc. 2019 Employee Stock Purchase Plan Adopted by the Board of Directors: Approved by the Stockholders: (January 11th, 2019)
Youngevity International, Inc. – Youngevity International, Inc. Second Amended and Restated 2012 Stock Option Plan (January 11th, 2019)
Generex Biotechnology Corporation – Contract (January 11th, 2019)

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR QUALIFIED UNDER ANY OTHER APPLICABLE SECURITIES LAWS. AS A RESULT, NO SALE OR TRANSFER OF THIS NOTE MAY BE MADE EXCEPT IN COMPLIANCE WITH OR PURSUANT TO AN EXEMPTION FROM SUCH LAWS.

THL Credit, Inc. – Amended and Restated By-Laws of Thl Credit, Inc. (January 11th, 2019)
Currencyshares Canadian Dlr – Amendment to the FXA Agreement. (January 11th, 2019)
Currencyshares British Pound – Amendment to the FXA Agreement. (January 11th, 2019)
Currencyshares Euro Trust – Amendment to the FXA Agreement. (January 11th, 2019)
CREDIT AGREEMENT Dated as of January 7, 2019 Among COHERUS BIOSCIENCES, INC., as the Borrower, CERTAIN DOMESTIC SUBSIDIARIES OF THE BORROWER, as the Guarantors, HCR COLLATERAL MANAGEMENT, LLC, as the Administrative Agent and THE LENDERS FROM TIME TO TIME PARTY HERETO (January 11th, 2019)
Monster Digital, Inc. – Option to Purchase Senior Convertible Note (January 11th, 2019)

This option is granted and effective as of January 7, 2019 (the "Effective Date") by and between Gustavia Capital Partners LLC and/or its affiliates, the holders of the Senior Convertible Note originally issued to Gustavia Capital Partners LLC (collectively, "Holder") and Innovate Biopharmaceuticals, Inc., a Delaware corporation ("INNT" or the "Company").

Kaleido Biosciences, Inc. – XCHANGE AT BEDFORD LEASE Between DIV BEDFORD, LLC, as Landlord and KALEIDO BIOSCIENCES, INC., as Tenant (January 11th, 2019)
[Face of Note] (January 11th, 2019)

Unless this certificate is presented by an authorized representative of The Depository Trust Company, a New York corporation ("DTC"), to the Company or its agent for registration of transfer, exchange or payment, and any certificate issued is registered in the name of Cede & Co. or in such other name as requested by an authorized representative of DTC (and any payment is made to Cede & Co. or such other entity as is requested by an authorized representative of DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL inasmuch as the registered owner hereof, Cede & Co., has an interest herein.

Currencyshares Chinese Renminbi Trust – Amendment to the FXA Agreement. (January 11th, 2019)
AVROBIO, Inc. – Separation Agreement and Release (January 11th, 2019)
$400,000,000 4.07% Senior Notes, Series A, Due March 13, 2026 (January 11th, 2019)

Paychex of New York LLC, a Delaware limited liability company (the "Company"), and Paychex, Inc., a Delaware corporation (the "Parent" and collectively with the Company, the "Obligors"), jointly and severally, agree with each of the Purchasers as follows:

Cirius Therapeutics, Inc. – Cirius Therapeutics, Inc. 2019 Equity Incentive Plan Adopted by the Board of Directors: Approved by the Stockholders: Ipo Date: (January 11th, 2019)
Kaleido Biosciences, Inc. – Kaleido Biosciences, Inc. Loan and Security Agreement (January 11th, 2019)
Ianchulev Tsontcho – National Securities Corporation (January 11th, 2019)
Pivotal Acquisition Corp – Warrant Agreement (January 11th, 2019)
Pivotal Acquisition Corp – Registration Rights Agreement (January 11th, 2019)
Cirius Therapeutics, Inc. – CIRIUS THERAPEUTICS, INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: March 24, 2017 APPROVED BY THE STOCKHOLDERS: March 24, 2017 AMENDED BY THE BOARD OF DIRECTORS: August 22, 2018 APPROVED BY THE STOCKHOLDERS: August 22, 2018 AMENDED BY THE BOARD OF DIRECTORS: October 26, 2018 APPROVED BY THE STOCKHOLDERS: November 23, 2018 TERMINATION DATE: March 24, 2027 (January 11th, 2019)
Pivotal Acquisition Corp – Warrant (January 11th, 2019)
Roadrunner Transportation Systems Inc – FORM 2-Transfer TO DESIGNATED TRANSFEREE to Transfer Your Subscription Rights to Another Person, Complete This Form 2 and Have Your Signature Guaranteed Under Form 5. For Value Received ______________ of the Subscription Rights Represented by This Subscription Rights Certificate Are Assigned To: IMPORTANT: The Signature(s) Must Correspond With the Name(s) as Printed on the Reverse of This Subscription Rights Certificate in Every Particular, Without Alteration or Enlargement, or Any Other Change Whatsoever. FORM 3-Delivery TO DIFFERENT ADDRESS if You Wish for the Common Stock Underlying Your Su (January 11th, 2019)